ETOPOSIDE INJECTION
HIKMA CANADA LIMITED
Quick answers
Is there a shortage of ETOPOSIDE INJECTION in Canada?
No. There is no current shortage of ETOPOSIDE INJECTION 20MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
ETOPOSIDE INJECTION, USP
HOSPIRA HEALTHCARE ULC
ETOPOSIDE INJECTION USP
SANDOZ CANADA INCORPORATED
Other Products
VEPESID INJ 20MG/ML
BRISTOL LABS DIVISION OF BRISTOL-MYERS SQUIBB
PMS-ETOPOSIDE
PHARMASCIENCE INC
ETOPOSIDE - LIQ IV 20MG/ML
BDH INC.
DOM-ETOPOSIDE
DOMINION PHARMACAL
DIN
02552671
Strength
20MG
Dosage Form
Solution
Route
Intravenous
Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from HIKMA CANADA LIMITED
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
9MG · DIN 02304341
200MG · DIN 02459906
0.4MG · DIN 02432188
0.6MG · DIN 02432196
100MG · DIN 02507668
0.05MG · DIN 02457059
2MG · DIN 02457075
0.2% · DIN 02515377
1G · DIN 02437112
500MG · DIN 02437104
10G · DIN 02437120
2G · DIN 02499096